DTG
Dược phẩm Tipharco ·HNX ·2026Q1
▼ Slightly negative
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, DTG posted slightly lower profit versus the same period — an early signal that some factors are becoming less favorable — margins have been compressing consistently over multiple periods. What still needs to be determined is whether this is a temporary adjustment or an early sign of a weaker trend.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 70.7 | 124.1 | 68.7 | 65.9 | 58.3 | 148.4 | 66.0 | 82.9 | 66.7 | 131.0 | 73.6 | 78.3 |
| Growth | -43% | +81% | +4% | +13% | -61% | +125% | -20% | +24% | -49% | +78% | -6% | — |
| Net Income | 6.0 | 11.3 | 0.9 | 0.3 | 0.3 | 10.1 | 3.0 | 5.7 | 4.3 | 13.6 | 3.9 | 3.9 |
| Net Margin | 8.52% | 9.08% | 1.33% | 0.44% | 0.60% | 6.84% | 4.53% | 6.86% | 6.46% | 10.39% | 5.29% | 5.02% |
Drivers of DTG's profit
Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from 10.7% to 9.4% — leverage weakened the most, though net margin still provided support.
Is the profit sustainable?
Margins are improving and earnings quality is solid — a durable foundation for ROE.
What is driving the margin?
Net margin stands at 5.61%, broadly flat versus the same period. Supportive factors and pressure points are offsetting one another.
Margin is nearly flat but the underlying components are moving — this is a transitional phase, more time is needed to see the real trend.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Evaluate capital, asset, and working-capital efficiency.
Is capital being deployed efficiently?
ROIC edged up to 8.33%, rising 0.7pp. That translates to 8.33 in after-tax operating profit for every 100 units of operating capital. The main driver is capital turnover rose 0.12x — the business is generating more revenue per unit of capital, with NOPAT margin steady; with invested capital holding roughly steady.
Capital efficiency improved through turnover — a positive sign for asset efficiency, but this momentum needs to hold as capital expands.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
Balance sheet is exceptionally sound — liabilities at 0.41x equity, with a net cash position equivalent to 0.17x equity.
Inventory ended the period at 80.4bn, roughly 28.8% of total assets.
Over the last 12 months, working capital released 79.9bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 16.9 days versus the same period last year. The main moves came from DIO fell 34.4 days, DSO rose 9.4 days, and DPO fell 8.1 days.
Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.
Watchpoints
CCC stands at 174.7 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DSO increased by +9.4 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 99.8bn.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at -0.17x and interest coverage at 6.16x.
At present, short-term debt accounts for 100.0% of total debt, cash equals 210.5% of debt, and total debt stands at 30.9bn.
Watchpoints
Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 99.8bn in 2025, against investing cash flow of -0.6bn.
Post-investment cash flow was positive +99.2bn. Financing cash flow was negative +73.3bn.
CFO / net income was 6.09x.
Track how much investment can be funded internally from operating cash flow.
Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. Even so, cash generation still needs confirmation remains the area to verify in upcoming periods. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 175 days.
Improvement: earnings conversion looks more confirmed, with CFO / net income at 6.09x.
Watchpoint: Cash generation still needs confirmation.
Key risk: working capital remains tied up for too long, with cash cycle at 174.7 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Net Revenue
|
317.0 | 364.1 | 372.6 | 297.1 |
|
Cost of Goods Sold
|
250.5 | 286.2 | 284.9 | 227.9 |
|
Gross Profit
|
66.4 | 77.9 | 87.7 | 69.2 |
|
Financial Expenses
|
4.3 | 6.0 | 8.0 | 6.7 |
|
Selling Expenses
|
12.8 | 12.3 | 14.2 | 16.4 |
|
General and Administrative Expenses
|
34.7 | 31.2 | 28.5 | 25.7 |
|
Operating Profit
|
15.0 | 28.6 | 37.0 | 20.6 |
|
Profit Before Tax
|
15.2 | 29.0 | 37.7 | 21.4 |
|
Net Income
|
12.8 | 23.1 | 30.6 | 18.2 |
|
Profit Attributable to Parent
|
12.8 | 23.1 | 30.6 | 18.2 |
|
Earnings per Share
|
1,334.00 | 2,770.00 | 4,219.00 | 2,874.00 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.